Cell-free mitochondrial DNA activates AIM2 leading to Il-1β and IL-18-mediated inflammation in T2D patients (130) and AIM2 inhibition improved cardiac function in a diabetic rat model by blocking caspase-1 activity (131). Here, AIM2 is linked to type 2 diabetes mellitus.